Yusuf Berkcan Yanar

Yusuf Berkcan Yanar

Auto-generated profile, based on publicly available information

Yusuf Berkcan Yanar

Department of Medical Pharmacology, Faculty of Medicine, Bursa Uludag University, 16059 Bursa, Turkiye

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
YYYusuf Berkcan Yanar
Yusuf Berkcan Yanar
BABurçin Altınbaş
Burçin Altınbaş
SÇSinan Çavun
Sinan Çavun
MYMurat Yalcin
Murat Yalcin
MYMustafa Sertac Yilmaz
Mustafa Sertac Yilmaz
Given the cardiovascular effects of the cholinergic and cannabinoid systems, the present study aimed to investigate the interaction of both systems in hemorrhagic hypotensive conditions. Adult male Sprague Dawley albino rats were used in the study. Under sevoflurane anesthesia, the animals were catheterized in the left carotid arteries and jugular vein for monitoring cardiovascular parameters and producing hemorrhagic hypotension and intravenous (IV) injection, respectively. The hypotension was achieved by withdrawing a total volume of 2.2 mL blood/100g body weight over 10 minutes. The hemorrhage produced a severe and long-lasting decrease in mean arterial pressure (MAP). The IV injection of rimonabant (cannabinoid CB1 receptor antagonist) and DMSO promptly and significantly increased the MAP in the hypotensive rats. When administered at a sub-effective dose CDP-choline showed a slight increase in the MAP. However, when this same dose of CDP-choline was co-administered with DMSO, it elicited a more pronounced and prolonged increase in the MAP compared to the effects observed with CDP-choline or DMSO alone. Rimonabant partially inhibited the MAP-increasing effect of the sub-effective dose of CDP-choline administered with DMSO in the hypotensive rats. These findings suggest that CDP-choline demonstrates a synergistic interaction with DMSO, resulting in a heightened and prolonged increase in MAP during hemorrhagic hypotension. Conversely, it exhibits an antagonistic interaction with rimonabant in terms of their effects on MAP under similar conditions. These results can be interpreted as indicative of an interaction between cannabinoid CB1 receptors and the cholinergic system in the hemorrhagic hypotensive condition.

8 December 2025 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PEPinar Ellergezen
Pinar Ellergezen
YYYusuf Berkcan Yanar
Yusuf Berkcan Yanar
GÇGülce SEVDAR ÇEÇEN
Gülce SEVDAR ÇEÇEN
SÇSinan Çavun
Sinan Çavun
Prediabetes is a condition characterized by insulin resistance, impaired glucose tolerance, and metabolic imbalance, occurring before the onset of diabetes. Angiopoietin-like protein 4 (ANGPTL4), known for its role in lipid metabolism and energy regulation, has been proposed as a potential biomarker in the progression of prediabetes due to its regulatory role in lipid metabolism and systemic metabolic homeostasis. However, data on ANGPTL4 levels in prediabetic individuals and their association with metabolic parameters remain limited. This study aimed to investigate ANGPTL4 levels in a rat model of prediabetes and assess its relationship with key metabolic indicators. Male Wistar rats (6–8 weeks old) were randomly assigned to two groups: prediabetic (n=24) and healthy controls (n=22). The prediabetic group was fed a high-fat diet for 12 weeks, while the control group received a standard diet. Blood samples were collected, and ANGPTL4 levels were measured using the ELISA method. Metabolic parameters were also evaluated, including glucose, insulin, HbA1c, lipid profile (total cholesterol, LDL, HDL, triglycerides), HOMA-IR, and HOMA-β. ANGPTL4 levels were significantly elevated in the prediabetic group compared to controls (p

29 July 2025 in Journal of Research in Veterinary Medicine
Verified
Journal Article
Closed access
MYMurat Yalcin
Murat Yalcin
YYYusuf Berkcan Yanar
Yusuf Berkcan Yanar
DUDuygu Udum
Duygu Udum
MYMustafa Sertac Yilmaz
Mustafa Sertac Yilmaz
Considering the anti-inflammatory and shock-reversing effects of nesfatin-1 (NESF-1), the current study aimed to investigate the changes in plasma NESF-1 levels in septic shock conditions that produce both hypotensive and inflammatory effects. The changes in parathyroid hormone (PTH) and calcitonin (CT) plasma levels, which have anti-inflammatory activity and play a role in regulating Ca metabolism, such as plasma NESF-1, in septic shock conditions, were also investigated in the study. In the current study, adult male Wistar albino rats were used. Under sevoflurane anesthesia, the animals were catheterized in the femoral arteries to provide monitoring of mean arterial pressure (MAP) and heart rate (HR), as well as for blood sampling. Then, the cecal ligation and incision (CLI) method was applied to rats to induce experimental septic shock. For control, sham-operated animals were used. The cardiovascular parameters of all animals were monitored for 3 hours starting from hour 0. In addition, 0.5 ml of blood samples in the tubes containing EDTA were collected from the animals through the arterial catheter at 0, 1, and 3 hours. NESF-1, PTH, and CT levels from plasma extracted from collected blood samples were measured using the ELISA method. Septic shock gradually caused a decrease in the MAP and an increase in the HR of the rats. Remarkably, animals in the septic shock group exhibited a statistically significant time-dependent increase in plasma NESF-1, PTH, and CT levels compared to the control group. This preliminary data, indicating an elevation in plasma levels of NESF-1, PTH, and CT in correlation with the severity of septic shock, suggests a potential protective role for endogenous NESF-1, PTH, and CT in the pathophysiology of septic shock. Additionally, these increases may be a prognostic biological indicator related to the severity of septic shock.

23 October 2026 in Discovery Medicine
Verified
Journal Article
Open access
PDF file
PEPinar Ellergezen
Pinar Ellergezen
YYYusuf Berkcan Yanar
Yusuf Berkcan Yanar
MYMustafa Sertac Yilmaz
Mustafa Sertac Yilmaz
SÇSinan Çavun
Sinan Çavun
Background: Sepsis involves profound immune and metabolic disturbances. This study investigated whether prophylactic short-chain fatty acid (SCFA) supplementation alters circulating immunometabolic biomarkers and biochemical markers of hepatic and renal injury in experimental sepsis.Methods: Male Wistar rats were assigned to four groups (n = 12/group) with independent 24-h and 48-h subgroups. Sepsis was induced by cecal ligation and puncture (CLP). A mixture of sodium acetate, propionate, and butyrate (60:20:20 molar ratio; total dose 500 mg/kg) was administered intraperitoneally for 7 days before CLP and discontinued after sepsis induction. Circulating immunometabolic and organ-injury-related markers were measured.Results: SCFA supplementation increased circulating G protein-coupled receptor 41 (GPR41)- and G protein-coupled receptor 43 (GPR43)-related marker concentrations and produced an overall increase in glucagon-like peptide-1 (GLP-1). Angiopoietin-like protein 4 (ANGPTL4) increased significantly in septic animals at both time points, whereas C1q/tumor necrosis factor-related protein 3 (CTRP3) was not significantly altered by SCFA supplementation within septic animals. Circulating NOD-like receptor family pyrin domain-containing protein 3 (NLRP3)-related marker concentrations were reduced at 24 h and 48 h, while NLRP6-related marker concentrations were reduced at 48 h. SCFA supplementation also reduced alanine aminotransferase (ALT), urea, and creatinine at both time points and aspartate aminotransferase (AST) at 48 h. Other adipokine and metabolic marker responses were marker- and time-dependent.Conclusion: Prophylactic SCFA supplementation was associated with changes in circulating immunometabolic biomarkers and reductions in biochemical markers of hepatic and renal injury in CLP-induced sepsis. These findings require further tissue-based and therapeutic investigation.